CB-1093

N/A

Report date: 2022/08/23 20:00:44
NME

Base Information

Drug NameCB-1093
Drug Alias NameN/A
ClassificationSmall molecules > Amino acid supplement, Lipids and VitaminsSmall molecules > Heterocyclic drugs
Mechanisms of ActionBrain-derived neurotrophic factor modulatorsNerve growth factor modulators
TargetsNerve growth factorBrain-derived neurotrophic factor
Therapy Area/IndicationsNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesDenmark
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLeo Pharma A/S
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCephalonLeo Pharma A/S
Active IndicationsN/A
Inactive IndicationsNervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A